The partnership leverages PPD’s pediatric clinical trial experience, regulatory knowledge, and site and pediatric patient networks, and Quotient’s expertise in pediatric formulation development, drug ...

You'd think the emergence of a fatal disease—especially one that can be spread without physical contact—would be a big story. Yet a threatening new form of tuberculosis called extremely drug-resistant ...

While the vaccines are products of private sector innovation, their evaluation has been firmly anchored in public science, ...

In the world of tuberculosis (TB) control, it is the worst-case scenario. Doctors in Mumbai, India, reported last month they are seeing a group of patients infected with what they called "totally drug ...

Tuberculosis, which kills around 1,000 people a day in India, has acquired a deadlier edge. A new entity, whic is ominously called Totally Drug-Resistant TB. While Iran first reported TDRTB cases ...